Skip to content

Iovance Biotherapeutics

US · IOVA #1864 by market cap Listed 1970
6.90 -0.41 -5.61%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:59

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Goldman Sachs moved from Sell to Buy on 2026-09-24.

Analyst consensus 8 analysts

Buy
Avg price target 16.38 +137.4%
Price target rangecurrent 6.90
Low11.00
Avg16.38
High20.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-11 H.C. Wainwright -- Buy 20.00
2026-11-06 Citizens JMP -- Buy 12.00
2026-11-06 Barclays -- Buy 19.00
2026-11-05 H.C. Wainwright -- Buy 20.00
2026-10-29 Wells Fargo -- Buy 18.00
2026-10-29 H.C. Wainwright -- Buy 20.00
2026-10-29 Barclays -- Buy 18.00
2026-10-27 Barclays -- Buy 18.00
2026-10-26 H.C. Wainwright -- Buy 20.00
2026-10-23 Jefferies -- Buy 20.00
2026-10-13 Barclays -- Buy 18.00
2026-10-12 Jefferies -- Buy 20.00
2026-09-30 Wells Fargo -- Buy 18.00
2026-09-30 H.C. Wainwright -- Buy 20.00
2026-09-29 TD Cowen -- Buy 16.00
2026-09-29 Wells Fargo -- Buy 18.00
2026-09-29 H.C. Wainwright -- Buy 20.00
2026-09-29 Barclays -- Buy 15.00
2026-09-24 Goldman Sachs -- Buy 15.00
2026-09-17 Barclays -- Buy 15.00
2026-08-25 TD Cowen -- Buy 10.00
2026-08-17 Mizuho Securities -- Buy 11.00
2026-08-07 Citizens JMP -- Buy 8.00
2026-08-07 Barclays -- Buy 13.00
2026-08-06 H.C. Wainwright -- Buy 9.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-09-24 Goldman Sachs Sell → Buy 15.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 -- ±12.73% -11.03% (in line)
2026/Q2 2026-08-06 -- ±29.65% +43.09% (beat)
2026/Q1 2026-05-07 -- ±15.83% -13.20% (in line)
2025/Q4 2026-02-24 -- ±18.34% +30.80% (beat)
2025/Q3 2025-11-06 -- ±24.86% +27.62% (beat)
2025/Q2 2025-08-07 After close ±34.92% -20.08% (in line)
2025/Q1 2025-05-08 After close ±27.44% -44.80% (beat)
2024/Q4 2025-02-27 After close ±25.10% -19.49% (in line)
2024/Q3 2024-11-07 After close ±19.14% -13.80% (in line)
2024/Q2 2024-08-08 After close ±29.91% +24.94% (in line)
2024/Q1 2024-05-09 After close ±17.71% -18.48% (beat)
2023/Q4 2024-02-28 After close ±11.80% -8.72% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:59:47 · For reference only, not investment advice and not tailored to your situation.

Iovance Biotherapeutics discussion 0 comments

Add a comment